- Lobbying
- Chase AND Thomas
Lobbying Arrangements Results for 'Chase Thomas'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details |
CHEVY CHASE BANK FSB
|
KING & SPALDING LLP | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Johnson & Johnson
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Medicare reimbursement for radiation oncology treatment. MACRA Implementation (PL No: 114-10) |
Radiation Therapy Alliance
|
THE MCMANUS GROUP | |||
Details H.R. 5397, Joe Fiandra Access to Home Infusion Act of 2023, issues related to Medicare coverage of home infusion; issues related to the implementation of the Inflation Reduction Act; H.R. 5539/S.31... |
Alnylam Pharmaceuticals, Inc.
|
in-house lobbying | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Zavante Therapeutics, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Spero Opco, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
The Medicines Company
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Tetraphase Pharmaceuticals
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Microbion Corporation
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details S 1395, Stop Unfair Practices in Credit Cards Act of 2007: entire bill. HR 5546, Credit Card Interchange Fees: banking. No specific bill number: Bear Sterns merger. S 1145, Patent Reform Act of 200... |
JPMorgan Chase & Co.
banking and financial services |
THE OB-C GROUP, LLC | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Merck & Co., Inc.
Client manufacturers and develops pharmaceuticals, vaccines and biologic therapies. |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Astellas Pharma US, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Issues related to financial services and payments |
Early Warning Services, LLC
|
Venable LLP | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
AstraZeneca
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
GlaxoSmithKline
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Allergan, Plc.
Allergan is a diversified global pharmaceutical company |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Medicare payment for inpatient antibiotics. |
Antimicrobial Innovation Alliance
|
THE MCMANUS GROUP | |||
Details General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure develop... |
Achaogen
|
THE MCMANUS GROUP | |||
Details Issues related health savings accounts (HSAs) and individual coverage health reimbursement arrangements (ICHRAs) including in H.R.3799 - CHOICE Arrangement Act. H.R. 5688, the Bipartisan HSA Impro... |
WEX Health
|
THE MCMANUS GROUP | |||
Details Trade negotiations, including the Trans-Atlantic Trade and Investment Partnership, Trans-Pacific Partnership Legislation related to cybersecurity. Tax reform proposals and related tax legislation. ... |
J.P. Morgan Chase Bank, N.A.
|
MONUMENT POLICY GROUP, LLC | |||
Details Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023. Site neutrality provisions... |
Ambulatory Surgery Center Association
|
THE MCMANUS GROUP | |||
Details Financial legislation Federal tax legislation relating to energy policy, re-authorization of agriculture programs and extension of temporary tax provisions |
STATE STREET BANK AND TRUST COMPANY
|
Venable LLP | |||
Details H.R. 1491; S. 1679; H.R. 2901; S. 2038 - Discussed home mortgage loan modifications, foreclosures, servicing, and refinancing; discussed housing finance reform and related issues; discussed flood i... |
JPMorgan Chase & Co.
|
in-house lobbying | |||
Details S. 2190 - Discussed bank regulatory policy. H.R.3881, S.1838-Discussed consumer protection, digital identification, credit reporting, and privacy issues related to financial services and products. ... |
JPMORGAN CHASE HOLDINGS LLC
|
in-house lobbying | |||
Details Legislative and regulatory issues affecting the banking industry, including: Issues related to rate caps and interchange fees; Issues related to private student lending; Issues related to consumer ... |
Discover Financial Services, Inc.
|
Venable LLP | |||
Details Regulatory implementation of S.2155 |
VantageScore Solutions, LLC
|
Venable LLP | |||
Details General pharmaceutical coverage and reimbursement issues, issues and activities affecting oncology, neurodegenerative and fertility products. Issues related to reforming and increasing transparenc... |
EMD Serono, Inc.
|
THE MCMANUS GROUP | |||
Details S 489, HR 940, S 170, S 1835, HR 3644, S 1963, S 3085, S 3047, S 2909, S 3677 - discussed home mortgage loan modifications, foreclosures, servicing, and refinancing; discussed the implications of G... |
J.P. MORGAN CHASE BANK, N.A.
|
in-house lobbying | |||
Details Support permanency for the New Markets Tax Credit; H.R. 2539 - The Rural Jobs Act; Implementation of allocation rounds. |
Partnership for Job Creation
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. ... |
PLASMA PROTEIN THERAPEUTICS ASSOCIATION
|
in-house lobbying | |||
Details Access and reimbursement of Part B Drugs in Medicare. Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act. H.R.... |
Digestive Health Physicians Association, Inc.
|
THE MCMANUS GROUP | |||
Details H.R.5391, S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act Access and reimbursement of Part B Drugs in Medicare. Continued expansion of Telehealth services including in the... |
Large Urology Group Practice Association
|
THE MCMANUS GROUP | |||
Details Issues related to Port Security and U.S. Customs and Border Protection. Issues related to Unmanned Aerial Systems. Securing Americas Ports of Entry Act (S.1253) Port Crane Security and Inspection A... |
American Association of Port Authorities
|
in-house lobbying | |||
Details Trade matters impacting auto industry, including Section 232 report and USMCA. Monitor discussions re tax extenders and the electric vehicle tax credit. |
Alliance of Automobile Manufacturers
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Global Forum on Steel Excess Capacity OECD Steel Committee Section 232 of the Trade Expansion Act Steel Section 232 exclusions process Commerce Department and ITC trade enforcement funding Eliminat... |
AMERICAN IRON AND STEEL INSTITUTE
|
in-house lobbying | |||
Details Investments in meat processing infrastructure Beef industry supply chain resiliency efforts Cattle Contract Library Act (H.R. 5609) Meat & Poultry Special Investigator Act (H.R. 4103/S. 2036) Sm... |
National Cattlemen's Beef Association
|
in-house lobbying | |||
Details H.R. 766, Preventive Health Savings Act, all provisions S. 114, Preventive Health Savings Act, all provisions H.R. 5525, Continuing Appropriations and Border Security Enhancement Act, 2024, all pro... |
American Medical Association
|
in-house lobbying |